Barclays PLC Sells 126,642 Shares of Tenet Healthcare Corporation $THC

Barclays PLC lowered its holdings in Tenet Healthcare Corporation (NYSE:THC) by 49.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 130,574 shares of the company’s stock after selling 126,642 shares during the quarter. Barclays PLC owned about 0.15% of Tenet Healthcare worth $26,512,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Orion Porfolio Solutions LLC lifted its position in shares of Tenet Healthcare by 62.3% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 2,514 shares of the company’s stock worth $510,000 after buying an additional 965 shares in the last quarter. Integrated Quantitative Investments LLC bought a new position in shares of Tenet Healthcare in the third quarter valued at approximately $594,000. Cresset Asset Management LLC lifted its holdings in Tenet Healthcare by 51.6% during the third quarter. Cresset Asset Management LLC now owns 4,380 shares of the company’s stock worth $889,000 after acquiring an additional 1,491 shares during the period. Focus Partners Advisor Solutions LLC boosted its position in Tenet Healthcare by 104.9% in the third quarter. Focus Partners Advisor Solutions LLC now owns 7,569 shares of the company’s stock worth $1,496,000 after purchasing an additional 3,875 shares during the last quarter. Finally, Journey Strategic Wealth LLC boosted its holdings in shares of Tenet Healthcare by 25.3% in the 3rd quarter. Journey Strategic Wealth LLC now owns 1,714 shares of the company’s stock worth $348,000 after buying an additional 346 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Jefferies Financial Group lifted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Wells Fargo & Company reiterated an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Guggenheim raised their price objective on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a report on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $247.67.

Insiders Place Their Bets

In related news, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the transaction, the executive vice president owned 8,012 shares in the company, valued at $1,875,128.48. This trade represents a 74.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 42,195 shares of company stock worth $9,823,406. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Performance

Shares of NYSE THC opened at $234.73 on Thursday. The stock’s 50-day moving average is $212.38 and its 200 day moving average is $203.51. The stock has a market cap of $20.41 billion, a price-to-earnings ratio of 15.15, a P/E/G ratio of 1.17 and a beta of 1.39. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.